HRMY has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HRMY has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Harmony Biosciences Holdings's other inventories for the quarter that ended in Sep. 2024 was $0.0 Mil.
Harmony Biosciences Holdings's quarterly other inventories declined from Mar. 2024 ($0.0 Mil) to Jun. 2024 ($0.0 Mil) but then stayed the same from Jun. 2024 ($0.0 Mil) to Sep. 2024 ($0.0 Mil).
Harmony Biosciences Holdings's annual other inventories declined from Dec. 2021 ($0.0 Mil) to Dec. 2022 ($-0.0 Mil) but then increased from Dec. 2022 ($-0.0 Mil) to Dec. 2023 ($0.0 Mil).
The historical data trend for Harmony Biosciences Holdings's Inventories, Other can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Harmony Biosciences Holdings Annual Data | |||||||||||||||
Trend | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||
Inventories, Other | Get a 7-Day Free Trial | - | - | - | - | - |
Harmony Biosciences Holdings Quarterly Data | ||||||||||||||||||||
Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | |
Inventories, Other | Get a 7-Day Free Trial | - | - | - | - | - |
Other inventories including goods for resale, stocks in transit, consignment stocks, etc.
Marshman Fund Trust Ii | 10 percent owner | 630 W. GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING PA 19462 |
Valor Iv Pharma Holdings, Llc | 10 percent owner | 875 N. MICHIGAN AVENUE, SUITE 3214, CHICAGO IL 60611 |
Jeffrey Dierks | officer: Chief Commercial Officer | 630 W. GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING PA 19462 |
Peter Anastasiou | director | C/O HARMONY BIOSCIENCES HOLDINGS, INC., 630 W. GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING PA 19462 |
Jack Nielsen | director | C/O AKEBIA THERAPEUTICS, INC., 245 FIRST STREET, SUITE 1100, CAMBRIDGE MA 02142 |
Andreas Wicki | director | C/O HBM BIOVENTURES (CAYMAN) LTD., CENTENNIAL TOWERS,STE.305,2454 W.BAY RD., GRAND CAYMAN E9 E9 |
Andrew Serafin | officer: Chief Business Officer | 630 W. GERMANTOWN PIKE, PLYMOUTH MEETING PA 19462 |
Jeffrey M. Dayno | officer: Chief Medical Officer | 460 EAST SWEDESFORD ROAD, SUITE 1050, WAYNE PA 19087 |
John C Jacobs | director, officer: President, CEO | 630 W. GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING PA 19462 |
Linda M Szyper | director | C/O NEOS THERAPEUTICS, INC., 2940 N. HIGHWAY 250, SUITE 400, GRAND PRAIRIE TX 75050 |
Sandip Kapadia | officer: Chief Financial Officer | 450 WEST 15 STREET, SUITE 505, NEW YORK NY 10011 |
R. Mark Graf | director | C/O DISCOVER FINANCIAL SERVICES, 2500 LAKE COOK ROAD, RIVERWOODS IL 60015 |
Eric L Motley | director | 1516 33RD STREET NW, WASHINGTON DC 20007 |
Valor Equity Partners Iv-a L.p. | 10 percent owner | 875 NORTH MICHIGAN AVENUE, SUITE 3214, CHICAGO IL 60611 |
Novo Holdings A/s | 10 percent owner | TUBORG HAVNEVEJ 19, HELLERUP G7 2900 |
From GuruFocus
By GuruFocus News • 10-29-2024
By PRNewswire • 04-03-2024
By GuruFocus News • 10-07-2024
By PRNewswire • 05-28-2024
By PRNewswire • 08-21-2024
By PRNewswire • 12-03-2024
By PRNewswire • 04-11-2024
By GuruFocus Research • 08-06-2024
By GuruFocus News • 10-09-2024
By GuruFocus Research • 05-01-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.